359
Views
28
CrossRef citations to date
0
Altmetric
Biochemistry & Molecular Biology

LncRNA POU3F3 promotes proliferation and inhibits apoptosis of cancer cells in triple-negative breast cancer by inactivating caspase 9

, , , , &
Pages 1117-1123 | Received 14 Dec 2018, Accepted 09 Feb 2019, Published online: 07 Mar 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xian Hu Zhang, Bing Feng Li, Jie Ding, Lei Shi, Huo Ming Ren, Kui Liu, Chuan Cai Huang, Fu Xiao Ma & Xin Yao Wu. (2020) LncRNA DANCR-miR-758-3p-PAX6 Molecular Network Regulates Apoptosis and Autophagy of Breast Cancer Cells. Cancer Management and Research 12, pages 4073-4084.
Read now

Articles from other publishers (27)

Alina Catalina Palcau, Renata Brandi, Nikolay Hristov Mehterov, Claudio Botti, Giovanni Blandino & Claudio Pulito. (2023) Exploiting Long Non-Coding RNAs and Circular RNAs as Pharmacological Targets in Triple-Negative Breast Cancer Treatment. Cancers 15:16, pages 4181.
Crossref
Pablo Igor Ribeiro Franco, José Rodrigues do Carmo Neto, Liliana Borges de Menezes, Juliana Reis Machado & Marina Pacheco Miguel. (2023) Revisiting the hallmarks of cancer: A new look at long noncoding RNAs in breast cancer. Pathology - Research and Practice 243, pages 154381.
Crossref
Desh Deepak Singh, Hae-Jeung Lee & Dharmendra Kumar Yadav. (2023) Recent Clinical Advances on Long Non-Coding RNAs in Triple-Negative Breast Cancer. Cells 12:4, pages 674.
Crossref
Fei Shi, Jie Hu, Ping Zheng, Yisong Lv, Hongyu Liu, Guiyun Zhang & Hongyu Jiang. (2023) LncRNA PANTR1 is Associated with Poor Prognostic and Suppresses Apoptosis in Glioma. Journal of Oncology 2023, pages 1-14.
Crossref
Vandana Golhani, Suman Kumar Ray & Sukhes Mukherjee. (2022) Role of MicroRNAs and Long Non-Coding RNAs in Regulating Angiogenesis in Human Breast Cancer: A Molecular Medicine Perspective. Current Molecular Medicine 22:10, pages 882-893.
Crossref
Lin Wu, Xingmei Zhu, Runfeng Wang, Shukai Sun, Bo Ma & Zhiguo Zhang. (2022) The AKT/mTOR Signaling Pathway Was Mediated through the LINC00514/miR-28-5p/TRIM44 Axis. Disease Markers 2022, pages 1-9.
Crossref
Utpalendu Paul & Satarupa Banerjee. (2022) The functional significance and cross-talk of non-coding RNAs in triple negative and quadruple negative breast cancer. Molecular Biology Reports 49:7, pages 6899-6918.
Crossref
Jiayue Luo & Jianguo Lai. (2022) Pyroptosis‐related molecular classification and immune microenvironment infiltration in breast cancer: A novel therapeutic target. Journal of Cellular and Molecular Medicine 26:8, pages 2259-2272.
Crossref
Yuan Li, Xiangyi Kong, Zhongzhao Wang & Lixue Xuan. (2022) Recent advances of transcriptomics and proteomics in triple‐negative breast cancer prognosis assessment. Journal of Cellular and Molecular Medicine 26:5, pages 1351-1362.
Crossref
Manzoor A. Mir, Shariqa Aisha & Umar Mehraj. 2022. Combinational Therapy in Triple Negative Breast Cancer. Combinational Therapy in Triple Negative Breast Cancer 61 94 .
Yangkun Zhou, Yang Yue, Siyu Fan, Qiaojun Jia & Xianfeng Ding. (2021) Advances in Pathophysiology of Triple-Negative Breast Cancer: The Potential of lncRNAs for Clinical Diagnosis, Treatment, and Prognostic Monitoring. Molecular Biotechnology 63:12, pages 1093-1102.
Crossref
Krishan K. Thakur, Aviral Kumar, Kishore Banik, Elika Verma, Elina Khatoon, Choudhary Harsha, Gautam Sethi, Subash C. Gupta & Ajaikumar B. Kunnumakkara. (2021) Long noncoding RNAs in triple‐negative breast cancer: A new frontier in the regulation of tumorigenesis. Journal of Cellular Physiology 236:12, pages 7938-7965.
Crossref
Lanzhen Li, Zhongcheng Gao, Lei Zhao, Peiyou Ren & Hongyan Shen. (2021) Long non‐coding RNA LINC00607 silencing exerts antioncogenic effects on thyroid cancer through the CASP9 Promoter methylation. Journal of Cellular and Molecular Medicine 25:16, pages 7608-7620.
Crossref
Changle Ji, Jiashu Hu, Xuehui Wang, Wenfang Zheng, Xiaochong Deng, Hongming Song, Yunhe Yu, Qifeng Luo, Kaiyao Hua, Xiqian Zhou & Lin Fang. (2021) Hsa_circ_0053063 inhibits breast cancer cell proliferation via hsa_circ_0053063/hsa-miR-330-3p/PDCD4 axis. Aging 13:7, pages 9627-9645.
Crossref
Kai Wu, Qiang Wang, Yu-Lin Liu, Zhuo Xiang, Qing-Qing Wang, Li Yin & Shun-Li Liu. (2021) LncRNA POU3F3 Contributes to Dacarbazine Resistance of Human Melanoma Through the MiR-650/MGMT Axis. Frontiers in Oncology 11.
Crossref
Wen-Qing Gao, Xiao-Min Hu, Qiang Zhang, Lan Yang, Xin-Ze Lv, Shuang Chen, Peng Wu, Da-Wei Duan, Yu-Heng Lang, Meng Ning, Ke-Guan Lai, Zhi-Yuan Zhang, Bin Liang, Jing-Yu Bao, Hai-Dong Wu & Tong Li. (2020) Downregulation of circFASTKD1 ameliorates myocardial infarction by promoting angiogenesis. Aging 13:3, pages 3588-3604.
Crossref
Vasiliki Zolota, Vasiliki Tzelepi, Zoi Piperigkou, Helen Kourea, Efthymia Papakonstantinou, Maria-Ioanna Argentou & Nikos K. Karamanos. (2021) Epigenetic Alterations in Triple-Negative Breast Cancer—The Critical Role of Extracellular Matrix. Cancers 13:4, pages 713.
Crossref
Wenwen Zhang, Xiaoxiang Guan & Jinhai Tang. (2020) The long non‐coding RNA landscape in triple‐negative breast cancer. Cell Proliferation 54:2.
Crossref
Lei Zhang, Cezheng Wang & Min Ma. (2021) LncRNA POU3F3 Promotes Cancer Cell Proliferation, Migration, and Invasion in Renal Cell Carcinoma by Downregulating LncRNA GAS5. Kidney and Blood Pressure Research 46:5, pages 613-619.
Crossref
Taruna Rajagopal, Srikanth TalluriSivaramakrishnan Venkatabalasubramanian & Nageswara Rao Dunna. (2020) Multifaceted roles of long non-coding RNAs in triple-negative breast cancer: biology and clinical applications. Biochemical Society Transactions 48:6, pages 2791-2810.
Crossref
Simona Ruxandra Volovat, Constantin Volovat, Irina Hordila, Dorin-Alexandru Hordila, Ciprian Camil Mirestean, Oana Tatiana Miron, Cristian Lungulescu, Dragos Viorel Scripcariu, Cati Raluca Stolniceanu, Assia Adrianova Konsoulova-Kirova, Cristina Grigorescu, Cipriana Stefanescu, Cristian Constantin Volovat & Iolanda Augustin. (2020) MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review. Frontiers in Oncology 10.
Crossref
Julian Wolf, Claudia Auw-Haedrich, Anja Schlecht, Stefaniya Boneva, Hans Mittelviefhaus, Thabo Lapp, Hansjürgen Agostini, Thomas Reinhard, Günther Schlunck & Clemens A. K. Lange. (2020) Transcriptional characterization of conjunctival melanoma identifies the cellular tumor microenvironment and prognostic gene signatures. Scientific Reports 10:1.
Crossref
Shuo Zhang, Feixia Ma, Xiaohong Xie & Yong Shen. (2020) Prognostic value of long non-coding RNAs in triple negative breast cancer. Medicine 99:37, pages e21861.
Crossref
Juan Xu, Kang-jing Wu, Qiao-jun Jia & Xian-feng Ding. (2020) Roles of miRNA and IncRNA in triple-negative breast cancermiRNA 和 lncRNA在三阴性乳腺癌中的作用. Journal of Zhejiang University-SCIENCE B 21:9, pages 673-689.
Crossref
Sara Asgharzadeh, Farzaneh Tafvizi, Vahid Chaleshi & Shahrokh Iravani. (2020) Lack of association between LincRNA-Pou3f gene expression and clinicopathological features in gastric cancer tissue. Gene Reports 20, pages 100700.
Crossref
Maximilian Seles, Georg C. Hutterer, Johannes Foßelteder, Marek Svoboda, Margit Resel, Dominik A. Barth, Renate Pichler, Thomas Bauernhofer, Richard E. Zigeuner, Karl Pummer, Ondrej Slaby, Christiane Klec & Martin Pichler. (2020) Long Non-Coding RNA PANTR1 is Associated with Poor Prognosis and Influences Angiogenesis and Apoptosis in Clear-Cell Renal Cell Cancer. Cancers 12:5, pages 1200.
Crossref
Yang Chang-Qing, Liu Jie, Zhao Shi-Qi, Zhu Kun, Gong Zi-Qian, Xu Ran, Lu Hui-Meng, Zhou Ren-Bin, Zhao Gang, Yin Da-Chuan & Zhang Chen-Yan. (2020) Recent treatment progress of triple negative breast cancer. Progress in Biophysics and Molecular Biology 151, pages 40-53.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.